Medication info
Megastatin Tablet 2mg (Pitavastatin Calcium)

Megastatin Tablet 2mg (Pitavastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium›2mg / 1 tablet
Manufacturer / importer
Myungin Pharmaceutical Co., Ltd.
Appearance
Round film-coated tablet, white with a score line
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201306451 · Approved 2013.03.22 · Insurance code 651903840

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium once daily. If the reduction in LDL-cholesterol is inadequate, the dose may be increased to a maximum of 4 milligrams per day. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL-cholesterol level, treatment goal, and patient response. The therapeutic effect of this medicine is maintained with continued administration.

Ingredients

Manufacturer
Myungin Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
View approved original text

This medication helps treat patients with primary hypercholesterolemia and mixed dyslipidemia. Specifically, in patients with heterozygous familial hypercholesterolemia and non-familial hypercholesterolemia, Fredrickson type IIa and type IIb, it lowers total cholesterol, LDL cholesterol, apolipoprotein B levels, and triglyceride levels, supporting cardiovascular health. Additionally, it aids in raising HDL cholesterol levels to improve the balance of blood lipids. This efficacy is enhanced when used alongside dietary changes and plays a crucial role in managing hyperlipidemia. This medication is used to improve abnormal blood lipid levels and reduce the risk of cardiovascular disease.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The usual initial dose for adults is 1~2 milligrams of pitavastatin calcium once daily. If the reduction in LDL-cholesterol is inadequate, the dose may be increased to a maximum of 4 milligrams per day. Adjust the dose as appropriate at intervals of 4 weeks or longer according to the LDL-cholesterol level, treatment goal, and patient response. The therapeutic effect of this medicine is maintained with continued administration.

Precautions

This medication should not be used in certain patients. Those who have had allergic reactions to this medication, those with active liver disease or persistent unexplained liver enzyme elevations should not take this medication. Patients with severe liver dysfunction or bile duct obstruction, and those taking cyclosporine should also avoid using this medication. It is safest for patients with myopathy, women who are pregnant or may become pregnant, nursing women, and children to refrain from taking this medication. Patients who are lactose intolerant or have related genetic disorders should also avoid this medication. Care should be taken in patients with renal impairment or a history of liver disorders, excessive alcohol consumption, and those who are using certain lipid-lowering agents concurrently. Additionally, those with hypothyroidism or genetic muscle diseases, the elderly, and patients with severe myasthenia require careful administration. During the use of this medication, various side effects such as muscle pain or weakness, abnormal liver function, allergic reactions, gastrointestinal symptoms, and blood abnormalities may occur, so careful monitoring is required. If severe muscle pain, weakness, or liver function elevation occurs, discontinue use immediately and consult a physician. Since this medication is metabolized primarily in the liver, regular liver function tests should be conducted, and it is advisable to ensure adequate testing and dietary as well as exercise therapy before administration. Furthermore, concurrent use with certain medications increases the risk of renal function deterioration and muscle atypical reactions, so it's important to discuss with a physician whether to use them together. Elderly patients, pregnant and nursing women should be especially cautious and must not take this medication during pregnancy. Safety and effectiveness in children have not been established, so this medication is not used in children. This medication should be kept out of reach of children and stored in its original container to prevent misuse or deterioration of quality.

Side effects

  • Abdominal pain
  • rash
  • malaise
  • paralysis
  • itching
  • myalgia
  • weakness
  • elevated CPK levels
  • increased myoglobin in blood and urine
  • acute renal failure
Show 84 more
  • liver dysfunction
  • jaundice
  • thrombocytopenia
  • urticaria
  • erythema
  • angioedema
  • elevated bilirubin
  • increased cholinesterase
  • elevated AST
  • elevated ALT
  • elevated γ-GT
  • elevated ALP
  • elevated LDH
  • stiffness
  • drowsiness
  • insomnia
  • headache
  • heaviness in the head
  • dizziness
  • thirst
  • dyspepsia
  • abdominal bloating
  • constipation
  • stomatitis
  • vomiting
  • loss of appetite
  • glossitis
  • nausea
  • gastric discomfort
  • diarrhea
  • granulocytopenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • elevated globulin
  • positive Coombs test
  • anemia
  • increased frequency of urination
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • increased adrenocorticotropic hormone
  • increased cortisol
  • decreased testosterone
  • muscle cramps
  • feeling weak
  • palpitations
  • fatigue
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid levels
  • increased serum potassium and phosphorus
  • taste disturbances
  • malaise
  • positive antinuclear antibody
  • sleep disturbances
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • myasthenia gravis
  • ocular myasthenia
  • facial swelling
  • arm swelling
  • hypersensitivity
  • headache
  • dizziness
  • skin tingling
  • insomnia
  • sleep disturbances
  • loss of appetite
  • increased blood pressure
  • chest discomfort
  • weakness
  • nausea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a special container that doesn't allow light to enter. Additionally, the medication should ideally be stored at room temperature between 1 to 30 degrees Celsius. Avoid extreme heat or cold.

Appearance and packaging

Appearance

Round film-coated tablet, white with a score line

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.